Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
The BRAIN Act funds research into how the brain works and brain diseases.
The problem
Brain diseases like Alzheimer's and autism affect millions of Americans. Scientists need funding to understand these conditions better and find treatments.
The proposal
The bill allocates federal funding for brain research initiatives, grants to scientists, and programs studying neurological disorders and brain function.
The impact
Researchers gain resources to study brain diseases. Patients and families affected by neurological conditions may benefit from new treatments developed through funded research.
Funding brain research helps scientists understand diseases like Alzheimer's, Parkinson's, and autism. This knowledge can lead to new treatments and cures that improve people's lives.
Federal funding supports scientists, lab technicians, and support staff. These jobs strengthen the scientific workforce and research institutions across the country.
Brain diseases cost the economy billions in treatment and lost productivity. Research funded by this bill could reduce those costs long-term by preventing or treating diseases earlier.
Investment in brain research keeps America competitive in medical science globally. It attracts top scientists and positions the U.S. as a leader in neuroscience.
The bill requires government spending during a time of budget concerns. Some argue these funds could be used for other priorities or to reduce the deficit.
Brain research takes many years to produce practical treatments. Taxpayers may not see benefits for a long time, making the investment risky.
Federal agencies and private organizations already fund brain research. Critics question whether this bill wastes money by funding work that's already happening.
Research funding doesn't guarantee cures or treatments will be found. Money might be spent without producing breakthroughs that help patients.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.